Estradiol is the most biologically active form of estrogen in humans. Estrogens are steroid hormones made from cholesterol, and estradiol is the dominant estrogen during the reproductive years in women. In men and postmenopausal women, most estradiol is produced by converting testosterone into estradiol through an enzyme called aromatase. Aromatase is found in fat tissue, muscle, brain, and the testes. This means estradiol is not only an ovarian hormone. It is a whole body hormone.
Estradiol works by binding to estrogen receptors, which are proteins inside cells that act like molecular switches. The two main types are estrogen receptor alpha and estrogen receptor beta. When estradiol binds to these receptors, it changes gene expression, meaning it turns certain genes on or off. It also has faster signaling effects at the cell membrane through other receptor pathways. Through these mechanisms, estradiol influences bone remodeling, lipid metabolism, insulin sensitivity, vascular tone, brain signaling, and reproductive tissue function.
In bone, estradiol slows bone resorption, which is the breakdown of bone by cells called osteoclasts. Bone is constantly being remodeled through a balance between breakdown and formation. When estradiol falls too low, bone resorption accelerates and bone density declines. This is why menopause is strongly associated with osteoporosis in women. In men, very low estradiol levels, often below about 10 pg per mL, are associated with increased bone loss and fracture risk even if testosterone levels appear adequate. Rare men with aromatase deficiency or mutations in the estrogen receptor develop tall stature with unfused growth plates and severe osteoporosis, highlighting that estradiol is essential for male skeletal health.
In the cardiovascular system, estradiol affects endothelial function. The endothelium is the thin layer of cells lining blood vessels. Estradiol promotes nitric oxide production, which helps blood vessels relax and maintain flexibility. It also influences lipid metabolism, often supporting higher HDL cholesterol and more favorable lipid patterns in premenopausal women. After menopause, when estradiol declines sharply, cardiovascular risk rises. That shift reflects complex changes involving lipids, vascular inflammation, insulin sensitivity, and body fat distribution.
Estradiol plays a central role in reproductive function. In women, it regulates the menstrual cycle through a feedback loop involving the hypothalamus and pituitary gland. The hypothalamus releases gonadotropin releasing hormone, which stimulates the pituitary to release luteinizing hormone and follicle stimulating hormone. These hormones stimulate the ovaries to produce estradiol. Rising estradiol levels signal back to the brain to fine tune this system. Disruption anywhere along this axis can lead to abnormal estradiol levels. In men, estradiol supports spermatogenesis, which is the production of sperm, and contributes to libido and erectile physiology.
Elevated estradiol in women may occur with ovarian tumors, obesity, liver disease, pregnancy, or exogenous estrogen therapy such as hormone replacement or contraceptives. Fat tissue expresses aromatase, so higher body fat increases conversion of androgens into estrogens. In men, elevated estradiol is often seen with obesity, liver cirrhosis, testicular tumors, or high dose testosterone therapy. Excess estradiol in men can contribute to gynecomastia, which is enlargement of breast tissue, fluid retention, and suppression of natural testosterone production through feedback inhibition.
Low estradiol in women is most commonly seen in menopause, primary ovarian insufficiency, hypothalamic amenorrhea from under fueling or excessive exercise, or pituitary disorders. In men, low estradiol is usually secondary to low testosterone, since testosterone is the main precursor. Aromatase inhibitors, medications that block the conversion of testosterone to estradiol, can also reduce levels. Chronically low estradiol is associated with bone loss, changes in mood, altered lipid metabolism, and potentially higher cardiovascular risk depending on context.
For patients focused on lifespan and healthspan, estradiol should be viewed as a regulator of multiple systems, not just reproduction. Bone integrity, vascular function, body composition, and metabolic stability are all influenced by maintaining physiologic, not extreme, levels. Balance, rather than maximization or suppression, is the goal.